CIK: 0001458461
Total reported value
$50.7M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TYMEUSD | Tyme Technologies INC | Stock-Other | 21.92% | — | — | |
| 2 | GILD | Gilead Sciences INC | Stock-Healthcare | 21.89% | — | — | |
| 3 | PFE | Pfizer INC | Stock-Healthcare | 17.86% | — | — | |
| 4 | ✓ | Depomed INC | Stock-Other | 12.98% | — | +72.31% | |
| 5 | QLTUSD | Novelion Therapeutics INC | Stock-Other | 12.40% | — | +6.01% | |
| 6 | LAB | Standard Biotools INC | Stock-Other | 4.64% | — | -9.79% | |
| 7 | GSK | GSK plc ADRhedged | Stock-Healthcare | 4.06% | — | — | |
| 8 | ✓ | Amarin Corp PLC | Stock-Other | 3.15% | — | — | |
| 9 | ✓ | Proshares Tr | Stock-Other | 1.03% | — | -88.89% | |
| 10 | ✓ | Fibrocell Science INC | Stock-Other | 0.06% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences INC | +4.7% | — | Unchanged |
| 2 | PFE | Pfizer INC | +2.8% | — | Unchanged |
| 3 | LAB | Standard Biotools INC | +0.9% | -9.79% | Trim |
| 4 | ✓ | Depomed INC | +0.4% | +72.31% | Add |
| 5 | ✓ | Fibrocell Science INC | 0% | — | Unchanged |
| 6 | ✓ | Amarin Corp PLC | -0.1% | — | Unchanged |
| 7 | QLTUSD | Novelion Therapeutics INC | -1.4% | +6.01% | Add |
| 8 | ✓ | Proshares Tr | -8.8% | -88.89% | Trim |
| 9 | TYMEUSD | Tyme Technologies INC | — | NEW | New buy |
| 10 | AORT | Artivion INC | — | EXIT | Sold out |
| 11 | ✓ | — | EXIT | Sold out | |
| 12 | ✓ | Proshares Vix Short-term Futures ETF | — | EXIT | Sold out |
| 13 | TEVA | Teva Pharmaceutical-sp Adr | — | EXIT | Sold out |
| 14 | GSK | GSK plc ADRhedged | — | NEW | New buy |
| 15 | IMMU | Immunomedics INC | — | EXIT | Sold out |